Trisk Bio
PrivateLast Round
Series A
Jan 17, 2022
Total Funding Raised
$2.82M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Trisk Bio operates in Healthcare & Life Sciences and is based in Stevenage. Its latest recorded funding round was a Series A round in January 2022.
Trisk Bio is a biotechnology company that operates as a specialist adeno-associated virus (AAV) contract development and manufacturing organization (CDMO) for the gene therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trisk Bio Comparables
Compare Trisk Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| uBriGene Biosciences | 81% | |
| Ascend | 81% | |
| Vector BioMed, Inc. | 80% |
For institutional investors. Book with your work email.
Trisk Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 17, 2022 | ||||
| Seed | Dec 3, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trisk Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series A, Seed |
| Acequia Capital | Series A, Seed |
| Bluebirds Capital | Seed |
| GoodFriends | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 39% MoM, reaching 1.4K.
- Apr 17, 2026
Monthly visitors increased 66% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Trisk Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trisk Bio's valuation, stock price, and market status.
Is Trisk Bio a public or private company?
Trisk Bio is a private company.
What is the current stock price of Trisk Bio?
Trisk Bio is a private company, so its shares have no public market price. Caplight tracks Trisk Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trisk Bio worth (valuation)?
Valuation information for Trisk Bio is not publicly available.
Can I buy Trisk Bio stock?
Trisk Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trisk Bio's last funding round?
Trisk Bio's most recent funding round was Series A on January 17, 2022.
Who are the main investors in Trisk Bio?
Key investors in Trisk Bio include Matrix.
Will Trisk Bio IPO soon?
No public IPO plans have been announced for Trisk Bio.
How can I track Trisk Bio secondary market activity?
Caplight tracks bids, offers, and trades in Trisk Bio's shares on secondary markets.